Alzheimer's Disease - The First Drug in a Generation

In this week's episode Helena and Isabel were honoured to be joined by Rino Rappuoli, Head of External R&D and Chief Scientist at GSK Vaccines. He discusses his career inspiration and journey; his work on novel scientific concepts such as reverse vaccinology, which modern vaccines are based on; and his interest in meningitis, as well as the lasting impact of COVID-19 on the vaccine landscape, how he sees the field developing in future and what investment and innovation is needed from pharma to achieve his vision.

If you're interested in learning more about the topic areas discussed in this episode, check out the following content:

Keeping the spark alive in vaccine development https://www.emg-gold.com/post/keeping-the-spark-alive-in-vaccine-development

GSK's Judy Stewart on vaccines https://www.emg-gold.com/post/we-ve-lost-the-focus-that-we-had-on-routine-vaccination-of-preventable-diseases

The return of the vaccines https://www.emg-gold.com/post/the-return-of-the-vaccines

Is mRNA the future of vaccine technology? https://www.emg-gold.com/_files/ugd/b8a9db_63ca75dce7a64cd39b356ac1ffb18358.pdf